After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Chimerix Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Chimerix Inc is $799.21M. A total of 1.23 million shares were traded on the day, compared to an average of 4.02M shares.
In the most recent transaction, Melemed Allen S. sold 3,065 shares of CMRX for 4.50 per share on Feb 13 ’25. After the transaction, the CHIEF MEDICAL OFFICER now owns 152,875 company shares. In a previous transaction on Feb 13 ’25, Andriole Michael T. sold 7,370 shares at 4.52 per share. CMRX shares that PRESIDENT AND CEO owns now total 609,603.
Among the insiders who sold shares, Alrutz Michael Albert disposed of 1,600 shares on Feb 13 ’25 at a per-share price of $4.52. This resulted in the SVP AND GENERAL COUNSEL holding 213,596 shares of CMRX after the transaction. In another insider transaction, Jakeman David sold 300 shares at $4.53 per share on Feb 13 ’25. Company shares held by the VP OF FINANCE AND ACCOUNTING now total 148,987.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, CMRX has a high of $8.53 and a low of $0.75.
As of this writing, CMRX has an earnings estimate of -$0.27 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$0.27 per share and a lower estimate of -$0.27.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CMRX’s latest balance sheet shows that the firm has $88.37M in Cash & Short Term Investments as of fiscal 2021. There were $16.39M in debt and $29.90M in liabilities at the time. Its Book Value Per Share was $1.32, while its Total Shareholder’s Equity was $68.25M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CMRX is Buy with a score of 3.40.
